For example, it has been reported that miR-193a promotes apoptosis in cisplatin-resistant NSCLC cells by downregulating LRRC1 [37], indicating that high LRRC1 expression contributes to cisplatin resistance in NSCLC. The gene discussed is LRRC1; the disease is non-small cell lung carcinoma.